A new study finds that obesity significantly reduces the effectiveness of urate-lowering therapy in male gout patients, with ...

A new study finds no significant overall association between hormone therapy use and glioma risk in US women, although a ...

A new study finds that ursodeoxycholic acid (UDCA) effectively dissolves gallstones in 60% of patients after sleeve ...

ATOPIC dermatitis (AD) is a chronic inflammatory skin condition that significantly impacts patients’ quality of life. It is ...

Recent findings from the RESOLVE-1 trial highlight mycophenolate mofetil's efficacy in treating diffuse cutaneous systemic ...

Expand your understanding of cardiovascular (CV) health in women experiencing menopause, and stay ahead of developments in ...

Experts stress the need for diversity in basic and clinical research, highlighting recruitment challenges, mentorship gaps, ...

A recent study reveals that nearly half of family surrogate decision-makers for stroke patients face substantial financial ...

Guttman-Yassky received research support, consulting, or lecture fees on atopic dermatitis from Regeneron, Sanofi, Pfizer, ...

Preliminary results from the MITO 40 study presented at ESGO 2025 suggest Niraparib as a promising maintenance treatment for ...

A DMT-based treatment for people with treatment-resistant depression (TRD) has entered Phase 2 clinical trials.

IC31 did not reduce the risk of recurrent disease in individuals who completed treatment for pulmonary tuberculosis.